Haverford Trust Co Purchases New Position in Corteva, Inc. $CTVA

Haverford Trust Co acquired a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor acquired 65,206 shares of the company’s stock, valued at approximately $5,522,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. William B. Walkup & Associates Inc. boosted its position in shares of Corteva by 2.9% in the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after purchasing an additional 126 shares during the period. Wilkerson Advisory Group LLC lifted its stake in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after buying an additional 133 shares during the last quarter. AdvisorNet Financial Inc boosted its holdings in shares of Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after acquiring an additional 135 shares during the period. First Horizon Corp boosted its holdings in shares of Corteva by 9.2% in the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after acquiring an additional 135 shares during the period. Finally, Aviance Capital Partners LLC grew its position in shares of Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock worth $922,000 after acquiring an additional 137 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 3.0%

CTVA opened at $81.84 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The stock has a market capitalization of $54.60 billion, a P/E ratio of 54.20, a P/E/G ratio of 2.51 and a beta of 0.57. The business has a 50 day simple moving average of $82.13 and a 200-day simple moving average of $80.21.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the prior year, the company posted $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is presently 47.68%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CTVA shares. Royal Bank Of Canada lifted their target price on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a report on Tuesday, July 21st. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Citigroup lifted their price objective on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Bank of America upped their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Finally, UBS Group lowered their price target on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a report on Tuesday. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, Corteva has an average rating of “Moderate Buy” and an average target price of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.